HNRNPA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.434380E-01
Normal-vs-Stage2
4.062200E-01
Normal-vs-Stage3
4.987000E-01
Normal-vs-Stage4
8.412400E-01
Stage1-vs-Stage2
2.869600E-01
Stage1-vs-Stage3
7.603200E-01
Stage1-vs-Stage4
1.299760E-01
Stage2-vs-Stage3
6.286200E-01
Stage2-vs-Stage4
5.299800E-01
Stage3-vs-Stage4
5.179400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.912400E-01
Normal-vs-AfricanAmerican
5.186400E-01
Normal-vs-Asian
3.547200E-01
Caucasian-vs-AfricanAmerican
9.257400E-01
Caucasian-vs-Asian
4.674400E-01
AfricanAmerican-vs-Asian
6.237600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.601200E-01
Normal-vs-Female
4.089200E-01
Male-vs-Female
9.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.638000E-01
Normal-vs-Age(41-60Yrs)
6.229600E-01
Normal-vs-Age(61-80Yrs)
3.054400E-01
Normal-vs-Age(81-100Yrs)
2.363000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.388000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.538600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.795600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.995700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.444600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.442200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.657200E-01
Normal-vs-Daily Drinker
2.001600E-01
Normal-vs-Weekly Drinker
4.031200E-01
Normal-vs-Occasional Drinker
6.806200E-01
Normal-vs-Social Drinker
6.257000E-01
Non Drinker-vs-Daily Drinker
5.409400E-01
Non Drinker-vs-Weekly Drinker
9.032200E-01
Non Drinker-vs-Occasional Drinker
2.309000E-01
Non Drinker-vs-Social Drinker
5.095200E-01
Daily Drinker-vs-Weekly Drinker
4.409600E-01
Daily Drinker-vs-Occasional Drinker
4.555900E-02
Daily Drinker-vs-Social Drinker
1.651770E-01
Weekly Drinker-vs-Occasional Drinker
2.966800E-01
Weekly Drinker-vs-Social Drinker
5.681000E-01
Occasional Drinker-vs-Social Drinker
7.230800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.623170E-01
Normal-vs-Grade 2
2.324000E-02
Normal-vs-Grade 3
4.210300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.720300E-02
Grade 1-vs-Grade 3
1.524340E-02
Grade 1-vs-Grade 4
1.623170E-01
Grade 2-vs-Grade 3
3.032400E-01
Grade 2-vs-Grade 4
2.324000E-02
Grade 3-vs-Grade 4
4.210300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.376600E-01
Normal-vs-NonDiabetic
3.820000E-01
Diabetic-vs-NonDiabetic
6.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.176800E-01
Normal-vs-NoPancreatitis
3.927000E-01
Pancreatitis-vs-NoPancreatitis
7.621600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.861200E-01
Normal-vs-N1
3.977600E-01
N0-vs-N1
9.015000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.482000E-01
Normal-vs-TP53-NonMutant
2.320400E-01
TP53-Mutant-vs-TP53-NonMutant
1.384250E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
